These figures come from common supplier reference protocols, not from approved human dosing
In the 3-KO and WT groups, male mice aged 1214 weeks were divided into three subgroups including: saline control, AOD9604 administered at a dose of 250 g/kg/day, and hGH administered at a dose of 1 mg/kg/day
Route Subcutaneous Published Dose Context Common research-context planning cites 300-500 mcg/day from a reconstituted vial
Discuss diabetes medications or thyroid history before interpreting weight or glucose changes
AOD-9604 Cycle Length and Protocol Duration Determining optimal cycle length depends on metabolic goals, baseline body composition, response to therapy, and physician assessment
Current use is limited to research purposes under physician supervision